Zhengtao Hong
No. 79 Qingchun Road
Hangzhou, 310003, China
Hangzhou, 310003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Tumor-associated CD19+ macrophages induce immunosuppressive microenvironment in hepatocellular carcinoma.
Journal: Nature communications
Published: March 22, 2025
Reciprocal regulation of MMP-28 and EGFR is required for sustaining proliferative signaling in PDAC.
Reciprocal regulation of MMP-28 and EGFR is required for sustaining proliferative signaling in PDAC.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 04, 2024
Targeting leucine-rich repeat serine/threonine-protein kinase 2 sensitizes pancreatic ductal adenocarcinoma to anti-PD-L1 immunotherapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 26, 2023
Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis.
Journal: Journal for immunotherapy of cancer
Published: February 05, 2022
Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy.
Journal: EBioMedicine
Published: December 01, 2021
A Seven-Gene Signature to Predict Prognosis of Patients With Hepatocellular Carcinoma.
Journal: Frontiers in genetics
Published: June 21, 2021
Preoperative transarterial chemoembolization for barcelona clinic liver cancer stage A/B hepatocellular carcinoma beyond the milan criteria: a propensity score matching analysis.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: August 04, 2020
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy.
Journal: Signal transduction and targeted therapy
Published: July 25, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026